Cargando…
Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies
Changes in protein metabolism are key to disease onset and progression in many neurodegenerative diseases. As a prime example, in Parkinson’s disease, folding, post-translational modification and recycling of the synaptic protein α-synuclein are clearly altered, leading to a progressive accumulation...
Autores principales: | Ebrahimi-Fakhari, Darius, Saidi, Laiq-Jan, Wahlster, Lara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046681/ https://www.ncbi.nlm.nih.gov/pubmed/24314025 http://dx.doi.org/10.1186/2051-5960-1-79 |
Ejemplares similares
-
International electives in the final year of German medical school education – a student's perspective
por: Ebrahimi-Fakhari, Darius, et al.
Publicado: (2014) -
Glucocerebrosidase Involvement in Parkinson Disease and Other Synucleinopathies
por: Almeida, Maria do Rosário
Publicado: (2012) -
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022) -
Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
por: Terkelsen, Miriam Højholt, et al.
Publicado: (2022) -
The HSP70 Molecular Chaperone Is Not Beneficial in a Mouse Model of α-synucleinopathy
por: Shimshek, Derya R., et al.
Publicado: (2010)